Korea’s drug watchdog OKs flu vaccine

Published: 2010-01-08 06:56:00

Updated: 2010-01-08 06:56:00

Korea’s drug safety watchdog said on January 5 that it has given Green Cross Corp. the green light to market Greenflu-S, a vaccine with adjuvant.

The final decision came after consultation with the Central Pharmaceutical Deliberation Committee last December.

Last September, under a deal wit...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK